A surfer without a degree is worth $16 billion after his biotech company's stock soared 1,100% in a year
Bob Duggan, an uneducated entrepreneur, became a biotech billionaire through Summit Therapeutics, exemplifying success outside traditional academic pathways. [ more ]
What is a cell type, really? The quest to categorize life's myriad forms
Cellular individuality complicates research, as each cell exhibits unique characteristics which may influence drug resistance in cancer treatment. [ more ]
A surfer without a degree is worth $16 billion after his biotech company's stock soared 1,100% in a year
Bob Duggan, an uneducated entrepreneur, became a biotech billionaire through Summit Therapeutics, exemplifying success outside traditional academic pathways. [ more ]
What is a cell type, really? The quest to categorize life's myriad forms
Cellular individuality complicates research, as each cell exhibits unique characteristics which may influence drug resistance in cancer treatment. [ more ]
If all creativity is problem-solving, there's never been a better time for our industry to train its guns on one of the biggest challenges of all: cancer.
Digital Twins May Enable Personalized Health Treatment
Creating digital twins of organs using patient data can lead to personalized treatments and prevent medical complications.
Efforts are underway to develop personalized heart models for patients with irregular heartbeats and digital twins of patients' tumors for cancer research.
There is also work being done to create digital twins for pregnancy to address potential complications. [ more ]